|
|
U.S.-CHINA PHARMA
May 23-24, 2011|The Hub Cira Center, Philadelphia
|
|
|
|
Conference Chairman:
Dr. Mikael Dolsten, President, Pfizer Worldwide Research and Development
A physician with more than 20 years experience in the pharmaceutical industry, Dr. Dolsten oversees thousands of world-class scientists and researchers and understands how important it is for today's U.S. bio-pharma leaders to have strong liaisons with their colleagues in China. |
|
|
Greetings!
Taking into account the industry-wide struggles including patent cliffs, skyrocketing R&D costs and failures in key trials for potentially landmark new drugs, we understand your pressure to bring products to market faster and cheaper. According to a new report from the Monitor Group, China will become the global leader in life science discovery and innovation within the next decade.
Join the U.S.-CHINA PHARMA in Philadelphia to learn first-hand how key entrepreneurs, life science executives, and academics are developing innovative new models for pharmaceutical R&D in China, using Chinese-led clinical research organizations to speed up their research in hopes of creating better drugs, faster and cheaper.
Meet face-to-face with hundreds of leaders and executives who are shaping collaborations between the United States and China, and walk away with partners for your next project!
|
|
Our distinguished speaker faculty includes:
- Mikael Dolsten,M.D., Ph.D., President, Pfizer Worldwide Research & Development
- Wim Vandenhouweele, Executive Director, Global Vaccines & Commercial Development, Merck & Co.
- Drew Natenshon, Head US Research Strategy and Operations, Novartis Vaccines & Diagnostics
- Li Chen, Ph.D., CEO, Hua Medicine
- Charles Hsu, Ph.D., MBA, Venture Partner, Bay City Capital
- Jing-Shan Hu, Ph.D., Director of Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Merck & Co.
- Murali Gopalakrishnan, Ph.D., Head, Global External Research, GPR&D, Abbott Laboratories
- David C. Christiani, M.D., M.P.H., M.S., Elkan Blout Professor of Environmental Genetics, Department of Environmental Health, Department of Epidemiology, Harvard School of Public Health
- Qingyi Wei, M.S., M.D., Ph.D., Professor (tenured), Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center
- Melvin Reichman, Ph.D., Director, LIMR Chemical Genomics Center (LCGC)
- Christopher Laing, MRCVS, Ph.D., Vice President, Science and Technology, University City Science Center
- Dr. Yuan-Hua Ding, Senior Director, Head of External R&D Innovation - Asia, Pfizer Worldwide Research & Development
- Wei Zhou, M.D., Ph.D., Co-Chair of Academic Relationships, USCACA; Director, Molecular Epidemiology Research, Global Outcome Research, Pfizer Oncology
- Wei Zhang, Ph.D., Principal, Safeguard Scientifics, Inc.
- R Stephen Porter, PharmD., Chief Scientific Officer, Dragon Bio-Consultants, Ltd.
- Dr. Dr. Frank Floether, Dr. Floether Consulting
- Patricia Weeks, Founder and President, Weeks Consulting
- Yiyou Chen, Ph.D., Chief Scientific Officer, Crown Biosciences Inc.
- Peng Chen, Partner, Morrison & Foerster LLP
- Yunling Ren, Ph.D., Esq., Counsel, Butzel Long
- Cyrus Chowdhury, Vice President and Practice Leader, Insight Strategy Advisors
|
|
|
If you are interested in sponsoring, exhibiting, or speaking opportunities, please contact Judy Tsui (twee) at judy@cypinproduction.com or call 917.338.7778.
|
|
Sincerely,
Judy Tsui
Cypin Production LLC |
|
|
|
|
Save up to $400 with FREE hotels
| Our early bird discount will end soon. Book and pay by Dec 15, 2010 and save up to $400. If your company is based in China, you may be eligible for TWO FREE NIGHTS at Westin Philadelphia. Please email judy@cypinproduction.com for details and to check eligibility.
| | Offer Expires: Dec 15, 2010 |
|
|
